"10.1371_journal.pone.0062378","plos one","2013-06-11T00:00:00Z","Vincent Kwok Lim Lam; Ronald Ching Wan Ma; Heung Man Lee; Cheng Hu; Kyong Soo Park; Hiroto Furuta; Ying Wang; Claudia Ha Ting Tam; Xueling Sim; Daniel Peng-Keat Ng; Jianjun Liu; Tien-Yin Wong; E Shyong Tai; Andrew P Morris; DIAGRAM Consortium; Nelson Leung Sang Tang; Jean Woo; Ping Chung Leung; Alice Pik Shan Kong; Risa Ozaki; Wei Ping Jia; Hong Kyu Lee; Kishio Nanjo; Gang Xu; Maggie Chor Yin Ng; Wing-Yee So; Juliana Chung Ngor Chan","Department of Medicine and Therapeutics, The Chinese University of Hong Kong, The Prince of Wales Hospital, Shatin, Hong Kong SAR, Peoples Republic of China; Department of Chemical Pathology, The Chinese University of Hong Kong, The Prince of Wales Hospital, Shatin, Hong Kong SAR, Peoples Republic of China; Department of Orthopaedics and Traumatology, The Chinese University of Hong Kong, The Prince of Wales Hospital, Shatin, Hong Kong SAR, Peoples Republic of China; Department of Endocrinology and Metabolism, Shanghai Diabetes Institute, Shanghai Key Laboratory of Diabetes Mellitus, Shanghai Clinical Center for Diabetes, Shanghai Key Clinical Center for Metabolic Disease, Shanghai Jiao Tong University Affiliated Sixth Peoples Hospital, Shanghai, Peoples Republic of China; Department of Molecular Medicine and Biopharmaceutical Sciences, Graduate School of Convergence Science and Technology and Department of Internal Medicine, College of Medicine, Seoul National University, Chongno-gu, Seoul, Korea; First Department of Medicine, Wakayama Medical University, Wakayama, Japan; Hong Kong Institute of Diabetes and Obesity, The Chinese University of Hong Kong, Hong Kong SAR, Peoples Republic of China; Li Ka Shing Institute of Health, The Chinese University of Hong Kong, The Prince of Wales Hospital, Shatin, Hong Kong SAR, Peoples Republic of China; Centre for Molecular Epidemiology, Saw Swee Hock School of Public Health, National University of Singapore, Singapore, Singapore; Saw Swee Hock School of Public Health, National University of Singapore, Singapore, Singapore; Genome Institute of Singapore, Agency for Science, Technology and Research, Singapore, Singapore; Singapore Eye Research Institute, Singapore National Eye Centre, Singapore, Singapore; Department of Ophthalmology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore; Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore; Duke-National University of Singapore Graduate Medical School, Singapore, Singapore; Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, United Kingdom","Â¶ Membership of the DIAGRAM Consortium is provided in Text S2.","J Chan, R Ma and WY So have filed the following PCT International patent application to claim the use of these genetic variants to predict diabetes and targeted therapies: Biomarkers for diabetes (PCT/CN2013/071053). V Steinthorsdottir, G Thorleifsson, GB Walters, A Kong, U Thorsteinsdottir and K Stefansson are employed by deCODE Genetics. RM Watanabe has pharmaceutical funding. JB Meigs currently has research grants from GlaxoSmithKline and Sanofi-Aventis and serves on consultancy boards for Eli Lilly and Interleukin Genetics. JC Florez has received consulting honoraria from Merck, bioStrategies, XOMA and Daiichi-Sankyo and has been a paid invited speaker at internal scientific seminars hosted by Pfizer and Alnylam Pharmaceuticals. RM Watanabe has received consulting honoraria from Merck & Co. and Vivus Inc., currently has a grant from Merck & Co., and received research material support from Takeda Pharmaceuticals North America. This does not alter the authors adherence to all the PLOS ONE policies on sharing data and materials. The authors have declared that no additional competing interests exist.","2013","06","Vincent Kwok Lim Lam","VKLL",27,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA
